End of the road for direct oral anticoagulants in thrombotic APS?

Nat Rev Rheumatol. 2019 Dec;15(12):697. doi: 10.1038/s41584-019-0335-2.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anticoagulants
  • Antiphospholipid Syndrome*
  • Humans
  • Rivaroxaban
  • Thrombosis*
  • Vitamin K

Substances

  • Anticoagulants
  • Vitamin K
  • Rivaroxaban